SUMMARY
Live vaccines historically afford superior protection, yet the cellular and molecular mechanisms mediating protective immunity remain unclear.
Here we found that vaccination of mice with live, but not dead, Gram-negative bacteria heightened follicular T helper cell (Tfh) differentiation, germinal center formation, and protective antibody production through the signaling adaptor TRIF.
Complementing the dead vaccine with an innate signature of bacterial viability, bacterial RNA, recapitulated these responses. The interferon (IFN) and inflammasome pathways downstream of TRIF orchestrated Tfh responses extrinsically to B cells and classical dendritic cells. Instead, CX3CR1 + CCR2 -monocytes instructed Tfh differentiation through interleukin-1b (IL-1b), a tightly regulated cytokine secreted upon TRIF-dependent IFN licensing of the inflammasome. Hierarchical production of IFN-b and IL-1b dictated Tfh differentiation and elicited the augmented humoral responses characteristic of live vaccines. These findings identify bacterial RNA, an innate signature of microbial viability, as a trigger for Tfh differentiation and suggest new approaches toward vaccine formulations for coordinating augmented Tfh and B cell responses.
INTRODUCTION
Major illnesses like poliomyelitis, yellow fever, pertussis, diphtheria, measles, mumps, rubella, tetanus, meningitis, and smallpox have all been controlled by vaccination (Plotkin and Plotkin, 2011) . Live vaccines can best induce long-term protective immunity, but concerns over their safety have caused increasing vaccine reluctance in the population (Detmer and Glenting, 2006; Lin et al., 2015) . Numerous vaccine preparations that do not rely on the inoculation of live microorganisms and consist of recombinant highly immunogenic proteins are also efficacious (Finco and Rappuoli, 2014) . However, many others are not as certain poorly characterized aspects of natural infection-not incorporated in most vaccines-are particularly effective at inducing the right combination of signals for generating protective immunity. The exact nature of these signals remains elusive.
We previously reported that the innate immune system can discern microbial viability by detecting molecules of microbial origin such as prokaryotic messenger RNA and cyclic-di-adenosine monophosphate, which are present in live bacteria and absent in dead bacteria (Blander and Sander, 2012; Moretti et al., 2017; Sander et al., 2011) . To test whether the molecular signatures of microbial viability could enhance the performance of a dead vaccine, we had found that inclusion of bacterial RNA as an adjuvant increased class-switched antibody titers in mice to levels similar to those induced by a counterpart live vaccine (Sander et al., 2011) (legend continued on next page) production, as well as inflammasome activation and its associated interleukin-1b (IL-1b) secretion and pyroptosis (Sander et al., 2011) . These responses were not made to dead bacteria (Sander et al., 2011) . A critical determinant of protection by many vaccines is the generation of high titers of isotype-switched, high-affinity neutralizing antibodies. The follicular T helper cell (Tfh) subset is specialized at helping B cells proliferate and differentiate into antibody secreting plasma cells and memory B cells (Crotty, 2014) . While the nature of cytokines, surface molecules, and transcription factors mediating either mouse or human Tfh differentiation have been defined, the physiological triggers remain unclear. We hypothesized that innate immune detection of microbial viability instructs Tfh differentiation.
To test our hypothesis, we evaluated the parameters impacting the antibody response in a vaccination model that engages the same innate pathways we had defined to be important in distinguishing live from dead Gram-negative bacteria (Sander et al., 2011) . We found that the live vaccine elicited better Tfh differentiation and germinal center formation than the dead vaccine, and these responses could be recapitulated by supplementing the dead vaccine with bacterial RNA. Tfh responses were critically dependent on TRIF expression in the non-B cell hematopoietic compartment, and CX3CR1 + CCR2 -monocytes were responsible for instructing the Tfh response after immunization with the live vaccine. Tfh responses also relied on the interferon regulatory factor 3 (IRF3) and inflammasome pathways responsible for the synthesis of IFN-b and IL-1b, respectively, and mobilized specifically by live bacteria and bacterial RNA. The ability of T cells to respond to IL-1b was critical for their differentiation into Tfh while IFN-b, known to license IL-1b production (Blander, 2014) , only promoted Tfh production of IL-21 without impacting Tfh lineage fate commitment. Our work provides the blueprint for designing new generations of vaccines that incorporate the signatures of microbial viability to achieve the superior protection of live vaccines without the associated health risks.
RESULTS
Protective Serum Antibodies to a Live Bacterial Vaccine Require TRIF We investigated the impact of bacterial viability and TRIF signaling on the ensuing adaptive immune response using an intraperitoneal vaccination model of WT and Trif À/À mice with either live or heatkilled (HK) Gram-negative E. coli (EC). To exclude the effects of replication or virulence factor activity, we chose a replication defective ThyA À avirulent K12 strain of EC (Sander et al., 2011) .
Consistent with our previous observations (Sander et al., 2011) , the live vaccine induced significantly higher titers of EC-specific IgG1, IgG2b, and IgG2c than the dead vaccine in WT mice (Figure 1A) . TRIF deficiency abrogated these differences ( Figure 1A ). Both the live and dead vaccines induced similar antibody titers in Trif À/À mice indicating their inability to signal innate detection of live bacteria ( Figure S1A ). TRIF deficiency also abrogated the IgG3 response, although this response was similar to both live and dead vaccines indicating its independence of bacterial viability ( Figure 1A ). This is consistent with predominance of IgG3 responses to polysaccharide antigens (Mond et al., 1995) shared between live and dead bacteria. TRIF deficiency had no effect on the IgM response ( Figure 1A ). Challenging vaccinated mice with live, replication-competent, ThyA-sufficient EC revealed lower splenic bacterial burdens in mice vaccinated with the live compared to dead vaccine ( Figure 1B ). TRIF deficiency negated the protective effects of the live vaccine indicating that TRIFdependent innate immune pathways are important for protection upon re-infection with Gram-negative bacteria ( Figure 1B ).
TRIF and Bacterial RNA Orchestrate a Robust B Cell Response
We had previously shown that vaccination with HKEC supplemented with bacterial RNA (HKEC+RNA) increases the serum titers of isotype-switched antibodies in mice to levels similar to those induced by live EC (Sander et al., 2011) . Figures 1C and 1D ) regardless of the time of analysis after vaccination ( Figure S1B ). The percentages of total B cells were not significantly different between WT and Trif À/À naive and vaccinated mice ( Figure S1C ). We stained spleen sections for B220, IgG, and GL7, a marker for cells in germinal centers (GC) where B cells proliferate, differentiate, and undergo antibody class-switch recombination (CSR) and affinity maturation (Swanson et al., 2013) . We found significantly increased numbers of GC and extra-follicular IgG production around B220-marked B cell follicles in the spleens of WT mice vaccinated with live compared to dead EC ( Figures 1E-1G and Figure S1D ). These responses were abrogated in Trif À/À mice and restored with the HKEC+RNA vaccine in WT but not Trif À/À mice ( Figures 1E-1G ).
These results suggested that follicular and extra-follicular IgG production was enhanced by the live and HKEC+RNA vaccines in a manner dependent on the specific TRIF signaling they engaged. We next examined the emergence of plasmablasts and plasma cells, as assessed by the upregulation of CD138 (Syndecan-1) and lack of GL7 expression ( Figure S1E ) (Nutt et al., 2015) . The combined percentages of CD138 +EC, n = 39; (D) WT (naive, n = 9 ;+EC, n = 15; +HKEC, n = 12; +HKEC+RNA, n = 9) and Trif À/À (naive, n = 9 ;+EC, n = 11; +HKEC, n = 8; +HKEC+RNA, n = 7); (F) and (G)
WT (naive, n = 4 ;+EC, n = 6; +HKEC, n = 5; +HKEC+RNA, n = 6) and Trif À/À (naive, n = 6 ;+EC, n = 5; +HKEC, n = 4; +HKEC+RNA, n = 4); (I) WT (naive, n = 9 ;+EC, n = 16; +HKEC, n = 12; +HKEC+RNA, n = 10) and Trif À/À (naive, n = 7 ;+EC, n = 11; +HKEC, n = 8; +HKEC+RNA, n = 8).
See also Figure S1 . Figures 1H and 1I) . We also noted an increase in intracellular IgG in CD138 + cells, characteristic of the high levels of antibody production by these cells (Nutt et al., 2015) , in WT but not Trif À/À mice after vaccination, with the strongest increases in response to live EC or HKEC+RNA compared to HKEC ( Figure 1J ).
TRIF and RNA Dependent Class-Switching in All B Cell Subsets B cells comprise a heterogeneous population of specialized cells with highly diverse biology and which contribute differentially to T-dependent and T-independent antibody responses (Swanson et al., 2013) . Intraperitoneal vaccination activates B1, B2, and marginal zone (MZ) B cells, all of which can undergo CSR into IgG + cells (Swanson et al., 2013) . We identified these B cell subsets, including B1a and B1b cells, in the spleens of vaccinated mice based on differential expression of CD23, CD21, CD43, and CD5 ( Figure 2A ) (Baumgarth, 2011) . As expected, the most abundant subset is follicular B2 cells (Table S1 ), which classically require T cell help to promote antibody class-switching within GC (Swanson et al., 2013 Figures 2B and 2C) . CSR in B cell follicles is impaired in the absence of T cell help (Crotty, 2014) . Indeed, vaccination of T cell-deficient Tcra À/À mice with live EC showed impaired antibody class-switching by follicular B2 cells, but also by extra-follicular B1a and B1b cells ( Figure 2D ), which can undergo CSR in a T-dependent manner (Erickson et al., 2001; Lee et al., 2011) . MZ B cells could still express IgG antibody (and at higher percentages) ( Figure 2D ), likely reflecting neutrophil-dependent help to MZ B cells through BAFF, APRIL, and IL-21 (Cerutti et al., 2013 (Table S2 ). These data suggested that B2 cells, which participate in GC reactions, were the major source of IgG in response to the live and HKEC+RNA vaccines. We also noted a significant increase in the percentages of these GL7 + CD138 -GC B cells ( Figure S1D ) upon vaccination of WT mice with live but not dead bacteria ( Figure 2E ). The HKEC+RNA vaccine significantly increased GC B cell percentages to levels comparable to those in live vaccine recipient WT mice ( Figure 2E ). Again, 'viability-induced' GC B cell generation was dependent on TRIF ( Figure 2E ), confirming our observations by immunofluorescence microscopy ( Figures 1E-1G Figure 1J ), postvaccination increases in IgG expression by GL7 + GC B cells in WT mice were predominantly surface-bound ( Figure 2F ). Collectively, these results indicated that TRIF-dependent detection of bacterial viability elicited GC B cell responses.
TRIF and Bacterial RNA Orchestrate a Tfh Response
We next investigated how innate detection of microbial viability impacts the generation of a Tfh response. We measured a significant increase in the transcript levels of the Tfh lineage defining transcription factor Bcl6 and signature cytokine IL-21 (Crotty, 2014) (naive, n = 3 ;+EC, n = 9); (E) and (G) WT(naive, n = 4 ;+EC, n = 9; +HKEC, n = 7; +HKEC+RNA, n = 7) and Trif À/À (naive, n = 4 ;+EC, n = 6; +HKEC, n = 4; +HKEC+RNA, n = 4). See also Figure S2 and Tables S1 and S2. Figure S3I ). Therefore, Tfh differentiation was driven by cognate antigen, and an inflammatory Tfh skewing milieu was not sufficient to drive Tfh differentiation of bystander CD4 + T cells. Additionally, RNA acted as an adjuvant in promoting antigen-dependent Tfh differentiation ( Figure S3I ). Collectively, these data indicated that within the context of a response to live Gramnegative bacteria, TRIF signaling was critical for Tfh differentiation and dispensable for Th1 differentiation. T cells were not altered ( Figure S4D ). After the initiation of Tfh differentiation, additional signals from B cells complete and maintain the Tfh differentiation program (Crotty, 2014) . To address the specific contribution of TRIF signaling in B cells versus non-B cell hematopoietic cells, we crossed B cell-deficient mMT mice to Trif À/À mice and subsequently generated mixed chimeric mice by reconstituting lethally irradiated C57BL/6J mice with 80% mMT BM ( NS, not significant (p > 0.05); *p < 0.05, **p % 0.01and ***p % 0.001 (two-tailed unpaired t test). Data are mean ± SEM. Numbers adjacent to outlined areas indicate percent of cells in gates. Data are representative of at least 3 independent experiments. Mouse numbers are in (E), (G) and (J) WT (naive, n = 11; +EC, n = 13; +HKEC, n = 15; +HKEC+RNA, n = 9) and Trif À/À (naive, n = 8; +EC, n = 9; +HKEC, n = 9; +HKEC+RNA, n = 7).
TRIF Signaling in B Cells
See also Figure S3 . and 3D-3G), the percentages of Tfh cells in mice where TRIF expression was intact on both B cells and non-hematopoietic cells were highest after vaccination with EC or HKEC+RNA compared to HKEC (Figures 4B and 4C ). Compared to these mice, confining TRIF deficiency to B cells did not significantly impair Tfh generation in response to the live or HKEC+RNA vaccines ( Figures 4B and 4C) . By contrast, the percentages of Tfh cells were significantly decreased when TRIF deficiency was limited to the non-B cell hematopoietic compartment indicating a role for B cell-extrinsic TRIF signaling in the Tfh response to bacterial viability ( Figures 4B and 4C ). These data excluded a role for B cell intrinsic TRIF signaling in Tfh differentiation, and pointed instead to a role for TRIF in myeloid antigen-presenting cells (APC) during the early phase of Tfh differentiation.
Monocyte-Derived Antigen-Presenting Cells Induce Tfh Differentiation via TRIF
Our results so far demonstrated a reliance of Tfh differentiation on TRIF and the hematopoietic CD11c + compartment, which encompasses different subsets of mononuclear phagocytes (MP) including DC, macrophages and monocytes. We next addressed the role of TRIF signaling in classical DC (cDC) whose differentiation relies on the zinc finger transcription factor, Zbtb46 (Meredith et al., 2012) . We generated mixed chimeric mice by reconstituting lethally irradiated C57BL/6J mice with 50% Zbtb46-DTR BM (Satpathy et al., 2012) and 50% Trif À/À BM. Injection of DT achieved partial (z60%) depletion of CD11c + MHC-II + cells as expected ( Figure S4E ), whereby after depletion of WT cDC, only Trif À/À cDC remained among other TRIF-deficient and TRIF-sufficient non-cDC. Vaccination of chimeric DT-treated mice with live EC still induced upregulation of Tfh markers ICOS and CXCR5 on CD4 T cells ( Figure S4E ) demonstrating no role for cDC-intrinsic TRIF signaling in Tfh differentiation. Macrophages and DCs secrete IL-1b uniquely in response to live and not dead Gram-negative bacteria (Sander et al., 2011) , thus we used IL-1b as a readout of the myeloid cell type that instructs Tfh differentiation. Intracellular staining of splenocytes for IL-1b at 5 hr post-injection of live EC revealed a small population of IL-1b-producing cells-not present in naive mice-that expressed high levels of MHC-II ( Figure 4D) Figure 4D ). IL-1b + MHC-II high cells also expressed CCR7 suggesting their localization to the T cell zone, as well as CD25, which quenches the Tfh inhibitory cytokine IL-2 and marks Tfh inducing cells ( Figure 4D ) (Li et al., 2016) . This expression profile was characteristic of monocytes and/or macrophages consistent with their lack of Zbtb46 expression (Satpathy et al., 2012) , and suggested the involvement of those cells in mediating the persistent Tfh response when Zbtb46 + cDC were depleted ( Figure S4E ).
In vitro stimulation of circulating leukocytes from Zbtb46-DTR mice with live EC in the presence of DT (to deplete cDC) led to the detection of a population of CD11b + cells which similar to that in vivo ( Figure 4D ) expressed CD11c, CD64, and CCR7 (Figure S4F) . After 4 days of co-culture with OT-II CD4 + T cells, Zbtb46-DTR leukocytes that had been stimulated with live EC-OVA induced OT-II T cell upregulation of CXCR5 and ICOS, and this induction persisted after cDC depletion with DT ( Figure 4E ). To show the capacity of non-cDC MP to induce Tfh differentiation in vivo after vaccination, we adoptively transferred circulating leukocytes from Zbtb46-DTR mice into Trif À/À mice, treated the mice with DT, and vaccinated them with live EC. Given that Trif À/À mice are impaired in their ability to induce Tfh differentiation (Figure 3 ), this strategy allowed us to determine that TRIF-sufficient non-cDC, remaining after depletion of TRIF-sufficient Zbtb46 + cDC, could rescue the impaired Tfh response in vaccinated Trif À/À mice ( Figure 4F ).
Restoration of the Tfh response also correlated with partial restoration of a GC B cell response ( Figure S4G ). Altogether these data indicated that a non-cDC cell type of monocyte and/or macrophage origin induced a Tfh response to live bacteria and further pinpointed TRIF signaling specifically in these cells as the driver of Tfh differentiation. + cells showed a significant decrease in Tfh induction compared to non-depleted mice after vaccination with live EC and no significant increase over that in naive mice ( Figure 4G and percentages shown in S4H). Given the lack of cDC involvement in the Tfh response to live EC (Figures 4E and 4F and S4E) , these data indicated the importance of CX3CR1-expressing monocytes in the Tfh response.
CX3CR1
To discriminate between the roles of CX3CR1 int Ly6C + and CX3CR1 (WT B cells)(naive, n = 9 ;+EC, n = 11; +HKEC, n = 10; +HKEC+RNA, n = 12); (F) naive, n = 5, +EC, n = 5; (G) CCR2-CFP-DTRÀDT(naive, n = 3, +EC, n = 5) CCR2-CFP-DTR+DT(naive, n = 3, +EC, n = 4); (H) CD11c-CRE À (naive, n = 3, +EC, n = 4) CD11c-CRE + (naive, n = 3, +EC, n = 6).
See also Figure S4 . and S5B), consistent with our previous findings (Sander et al., 2011) . Substantial Tfh differentiation has been reported in the combined absence of IL-6 and IL-21 indicating the existence of IL-6 and IL-21 independent pathways Figures 5D and 5E ). The augmented Tfh response with IFN-b and IL-1b correlated with an increase in GC formation under the same conditions (Figures 5F and 5G). The concentration of recombinant IL-1b injected with HKEC led to significantly more GC compared to live EC and likely exceeded IL-1b levels made endogenously to (naive, n = 4 ;+EC, n = 4); (B) WT(WT B cells)(naive, n = 10 ;+EC, n = 13; +HKEC, n = 10; +HKEC+RNA, n = 8), Irf3 À/À (WT B cells)(naive, n = 7 ;+EC, n = 10; +HKEC, n = 9; +HKEC+RNA, n = 9), Casp1
(WT B cells)(naive, n = 8 ;+EC, n = 10; +HKEC, n = 9; +HKEC+RNA, n = 9); (C) WT(naive, n = 7 ; +EC, n = 6; +HKEC, n = 7; +HKEC+IFN-b, n = 5; +HKEC+IL-1b, n = 12; +HKEC+IFN-b+IL-1b, n = 9) and Trif À/À (+EC, n = 4; +EC+IFN-b+IL-1b, n = 9); (E) WT+OTII T cells(+HKEC+RNA, n = 6; +HKEC+IFN-b+IL-1b, n = 8+HKEC+RNA, n = 8; +HKEC+IFN-b+IL-1b, n = 8); (G) WT(+EC, n = 5; +HKEC, n = 4; +HKEC+IFN-b, n = 6; +HKEC+IL-1b, n = 6; +HKEC+IFN-b+IL-1b, n = 6) and Trif À/À (+EC, n = 3; +EC+IFN-b+IL-1b, n = 4);
(H) WT(+EC, n = 25; +HKEC, n = 28; +HKEC+IFN-b+IL-1b, n = 23) and Trif (+EC, n = 22; +HKEC, n = 15; +HKEC+IFN-b+IL-1b, n = 18). See also Figure S5 .
live EC (Figures 5F and 5G ). The importance of IFN-b and IL-1b for GC formation was highlighted by the ability to rescue GC formation in Trif À/À mice in response to the live vaccine and to levels comparable to those in WT mice ( Figures 5F and 5G) . Injection of IFN-b and IL-1b with HKEC significantly increased serum titers of E. coli-specific IgG1, IgG2b, and IgG2c in WT mice compared to HKEC alone, and these titers were comparable to those in WT mice vaccinated with live EC ( Figure 5H ). Anti-E. coli IgM and IgG3 titers were similar among all groups of vaccinated WT mice ( Figure 5H ). When vaccination of Trif À/À mice with live EC was supplemented with IFN-b and IL-1b, the serum titers of IgG1 and IgG2c, but not IgG2b and IgG3, were significantly increased over those to live EC alone ( Figure 5H ). While the cytokine-driven increase in IgG2c titers remained significantly lower than those in WT live EC-vaccinated mice, IFN-b and IL-1b supplementation increased IgG1 titers to levels that were not significantly different than those in WT live EC-vaccinated mice ( Figure 5H ). Altogether, these data showed that the IFN-b and IL-1b effectors of the IRF3 and inflammasome pathways could augment vaccine-induced Tfh and GC responses, and to some extent, CSR of select IgG isotypes. Figures 6A and 6B ). The percentages of Ifnar À/À and Il1r1 À/À CD45.2 + T cells were similar after vaccination, and CD44 expression was increased to similar levels, excluding differences in activation ( Figure S6A ).
The levels of Tbx21 and Bcl6 transcripts in activated Ifnar À/À T cells were similar to those in WT T cells on day 5, whereas Il21 transcripts were significantly reduced, indicating a role for IFNAR in promoting IL-21 production ( Figure 6C ). Indeed, IFN-b promotes IL-21 production in human T cells (Strengell et al., 2004) , but also in murine T cells when in conjunction with IL-6 as the case here in the response to live EC (Nakayamada et al., 2014) . On the other hand, activated Il1r1 À/À T cells expressed significantly reduced Bcl6 and Il21 transcripts compared to WT T cells, whereas Tbx21 transcript levels were similar ( Figure 6C ). The critical role for IL1R1 in Tfh differentiation was supported by the inability of adoptively transferred MyD88 À/À CD45.2 + CD4 + T cells, deficient in the IL1R1 signaling adaptor MyD88, to increase expression of ICOS and CXCR5 upon vaccination with live EC ( Figure S6B ). This finding was consistent with a previous reported role for MyD88 in Tfh differentiation (Kubinak et al., 2015) . Collectively, these data indicated that during the response to live EC, IL-1b played a leading role in the Tfh response through T cell IL1R1-MyD88 signaling to induce expression of the master Tfh transcription factor Bcl6 and signature surface markers (ICOS, CXCR5). On the other hand, IFN-b played a supporting role through T cell IFNAR signaling to promote IL-21 production by already differentiated Tfh. See also Figure S6 .
DISCUSSION
Here we show that bacterial viability constitutes a physiological trigger for instruction of Tfh differentiation. In a mouse model of vaccination, specific detection of bacterial RNA within live Gram-negative bacteria, elicited Tfh cell differentiation and by consequence an isotype-switched antibody response. Human monocytes also discriminated between live and dead bacteria through detection of bacterial RNA and produced a distinct set of cytokines specifically in response to live bacteria including unpublished data) . Notably, the same innate trigger, bacterial RNA, led to Tfh differentiation in humans and mice, although the pathways involved and their cytokine outputs were different (L.S. and M. Ugolini, unpublished data) reflecting the known similarities and differences in the cytokine requirements for murine versus human Tfh differentiation . These data collectively indicate that the physiological triggers for Tfh cell differentiation are evolutionarily conserved in mice and humans despite divergence of the signaling pathways that shape Tfh differentiation in each species. Furthermore, distinct innate signaling modules that detect microbial viability might have evolved in these species to ensure pairing with the adaptive response most appropriate for the microbial threat encountered. The findings in both species provide a mechanistic basis for the superior performance of live vaccines. They solidify the promising potential of exploiting the molecular signatures of microbial viability as new adjuvants in vaccine design.
Within the context of a murine response to Gram-negative bacteria, innate detection of bacterial RNA engages the signaling adaptor TRIF upstream of a heightened IFN-b response and inflammasome-dependent IL-1b production. Cytosolic translocation of bacterial RNA upon phagocytosis of Gram-negative bacteria also engages the canonical NLRP3 inflammasome (Blander, 2014) . We found that the same pathways critically orchestrate the ensuing adaptive Tfh response in a series of sequential events that culminate in the production of cytokines that favor Tfh differentiation. These cytokines include IL-6, which plays a more dominant role in murine compared to human Tfh differentiation and is commonly induced by both live and dead bacteria, but also IFN-b and IL-1b (Blander and Sander, 2012; Sander et al., 2011) . The latter cytokines were important for murine 
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129mt/129mt mice, and indicated that IFN-b and IL-1b did not play redundant roles in Tfh differentiation. These roles relate to the hierarchical relationship between IFN-b and IL-1b during the earliest stages of an innate immune response to infection with Gram-negative bacteria. Bacterial RNA-mediated NLRP3 inflammasome activation (Sander et al., 2011) alongside LPS-mediated caspase-11 activation (Broz and Dixit, 2016) leads to mobilization of both the canonical and non-canonical inflammasomes in response to live EC (Blander, 2014) . In vitro studies have shown that DC and macrophage production of biologically active IL-1b in this case is contingent upon engagement of IFNAR on those cells by the IFN-b made as a direct result of TRIF signaling (Blander, 2014) . Indeed, TRIF licenses NLRP3 inflammasome and caspase-1 activation by enabling caspase-11 expression and activation via type-I IFN signaling (Blander, 2014) . Therefore, IFN-b production necessarily precedes that of IL-1b promoted the expression of various Tfh cell molecules including Bcl-6, while decreasing expression of the Bcl-6 antagonistic transcription factor Blimp-1 (Schmitt et al., 2014; Ueno et al., 2015) . When added directly to human CD4 + T cells, type-I IFN suppresses Bcl-6, CXCR5, and ICOS expression but promotes Blimp-1 and IL-21 expression (Schmitt et al., 2014; Wong et al., 2010) . Direct stimulation of naive CD4 T cells with different members of the type-I IFN cytokine family also suppressed CXCR5 and PD-1 expression (Locci et al., 2016) . Notably, type-I IFN-induced IL-27 expression through IFNAR signaling is paramount for the ability of dermal human CD14 + DC to instruct Tfh differentiation upon RIG-I signaling during Dengue virus infection (Sprokholt et al., 2017) . In a similar manner, type-I IFN signaling through IFNAR on mouse DC is critical for Tfh differentiation (Cucak et al., 2009 ). These findings in both human and mouse are consistent with ours in highlighting a primary role for type-I IFN in licensing innate cells for the instruction of Tfh differentiation. Therefore, type-I IFNs are important for inducing expression of the cytokines most conducive to Tfh differentiation with a lesser role on CD4 T cell directly. The increased adjuvanticity of bacterial RNA may stem from its ability to induce both IFN-b and IL-1b to optimize APC licensing for Tfh differentiation. Agents that directly activate the inflammasome could conceivably also mobilize a Tfh response. However, not all of these agents, like flagellin for example, induce a type-I IFN response, which as discussed above, is an important mediator of Tfh-promoting cytokines such as IL-27. It will be necessary to determine the relative contributions of the type-I IFN and inflammasome pathways to Tfh responses especially in humans.
The first signals for Tfh differentiation are provided at the stage of CD4 + T cell priming (Crotty, 2014 (Li et al., 2016) . Different APCs and pathways have been reported to drive mucosal antibody responses (Kanagavelu et al., 2016; Krishnaswamy et al., 2017; Leonardi et al., 2018) . In vaccination models, subcutaneous injection of incomplete Freund's adjuvant drives a Tfh response in an IFNAR and MyD88 dependent but IL-1b or IL-18 independent manner (Riteau et al., 2016) , whereas intraperitoneal injection of Alum induces strictly IL1b-dependent Tfh differentiation (Ritvo et al., 2017) . Our data point to the necessity of the TRIF-IFNb-IL1b axis specifically for immunization in the context of innate signals from both bacterial RNA and LPS. These studies indicate that the site of infection, class, and viability of the microbe, or composition of the vaccine are critical factors to consider when optimizing an antibody response.
Our studies point to the molecular signatures of bacterial viability and the unique innate pathways they elicit as critical determinants of the augmented humoral response to live bacterial vaccines. In the context of live Gram-negative bacteria, bacterial RNA and TRIF-dependent IRF3 and inflammasome activation effectively instruct murine Tfh and GC responses. New vaccine formulations that incorporate molecular signatures of microbial viability have the potential to effectively control infection and establish protective immunity against reinfection.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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STAR+METHODS KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-mouse CD11b, PE-Cy7, Clone M1/70 eBioscience Cat#25-0112-81
Anti-mouse CD11c, Alexa647, Clone N418 BioLegend Cat#117312
Anti-mouse CD11c, Alexa700, Clone N418 eBioscience Cat#56-0114-80
Determination of Bacterial Burdens in the Spleens of Vaccinated Mice Vaccinated mice were re-challenged 6 months after the first inoculation with 5x10 8 E. coli (DH5a, K12 strain). 24 hours after re-challenge, the spleens were homogenized in PBS and spread on LB agar plates and incubated overnight. Colony forming unit (CFU) were counted.
Fluorescence Activated Cell Sorting Total T cells and B cells were purified by magnetic bead isolation using specific anti-CD4 coated beads or anti-CD19 coated beads, respectively, according to the manufacturer's recommendations (Miltenyi Biotec). For specific follicular T helper cell isolation, we used a FACS Aria II (BD bioscience) with the antibody mixture used for Tfh monitoring. This mixture consisted of anti-ICOS (398.4A), anti-CD3 (2C11), anti-CD4 (GK1.5), anti-CD44 (IM7) (all from eBioscience), CXCR5 (2G8, BD bioscience), and the Aqua live/dead marker (Life Technologies).
Quantitative Real Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR) Total RNA was isolated from sorted T cells using the RNeasy kit (QIAGEN). Contaminating genomic DNA was removed by DNase digestion (DNase I, Roche). Reverse transcription was performed using Superscript III (Invitrogen) and cDNA was used for subsequent qRT-PCR reactions, which were conducted on an ABI Prism 7900 instrument using the Maxima SYBR green qPCR Master Mix (Fermentas) with the following primer pairs. All reactions were performed in duplicates and the samples were normalized to b-actin. were added 5 hours later in the presence of anti-IFN-g (40mg/ml), anti-IL-4 (40mg/ml) and anti-TGF-b (40mg/ml). Upregulation of ICOS and CXCR5 was assessed after 4 days of co-culture.
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QUANTIFICATION AND STATISTICAL ANALYSES
Statistical significance was determined by a two-sided unpaired Student's t test (GraphPad Prism). p < 0.05 was considered significant. NS, not significant *, p < 0.05; **, p % 0.01; ***, p % 0.001. Variances were similar among groups in all experiments. No specific randomization method was used for the animal experiments. Outlier values were excluded on the basis of the Grubbs' test. The sample sizes were chosen to ensure adequate power to detect percent change for each parameter according to recommendations by a consulted statistician. The investigators were not blinded to the group allocation during experiments and analyses.
